MedTrace Logo

Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning

NCT06163781 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7584

Last updated 2024-05-07

No results posted yet for this study

Summary

The goal of this clinical trial is to study whether the use of our blood culture prediction tool is non-inferior to current practice and if it can improve certain outcomes in all adult patients presenting to the emergency department with a clinical indication for a blood culture analysis (according to the treating physician). The primary endpoint is 30-day mortality. Key secondary outcomes are:

* hospital admission rates
* in-hospital mortality
* hospital length-of-stay. In the intervention group, the physician will follow the advice of our blood culture prediction tool.

In the comparison group all patients will undergo a blood culture analysis.

Conditions

  • Artificial Intelligence
  • Machine Learning
  • Microbiology
  • Emergency Service, Hospital
  • Randomized Controlled Trial

Interventions

DEVICE

Blood culture prediction tool

Machine learning based predicition tool

Sponsors & Collaborators

  • Amsterdam UMC, location VUmc

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-19
Primary Completion
2027-01-31
Completion
2027-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06163781 on ClinicalTrials.gov